In Treatment of Type 2 diabetes mellitus Trulicity 0.75mg Pre-Filled Pen is an injectable medicine that helps to control high blood glucose (sugar) levels. Lowering blood glucose levels is an essential part of managing diabetes. If you can control the level you will reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems, and loss of limbs. Proper control of diabetes may also lessen your risk of having a heart attack or stroke. Taking this medicine regularly along with a proper program of diet and exercise will help you live a normal, healthy life. You should keep using it for as long as it is prescribed as it is protecting your future health.
It is unsafe to consume alcohol with Trulicity 0.75mg Pre
Pregnancy : CONSULT YOUR DOCTOR
Filled Pen may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Trulicity 0.75mg Pre
Driving : CONSULT YOUR DOCTOR
Filled Pen alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Trulicity 0.75mg Pre
Filled Pen may not be needed in these patients. Please consult your doctor. Use of Trulicity 0.75mg Pre
Liver : SAFE IF PRESCRIBED
Filled Pen is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Trulicity 0.75mg Pre
If you miss a dose of Trulicity 0.75mg Pre-Filled Pen, take it as soon as you remember. If the next dose is to be taken within the next 72 hours, skip the missed dose. Do not take 2 doses of Trulicity 0.75mg Pre-Filled Pen within 72 hours of each other.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More